HEADER TRANSFERASE 15-FEB-07 2OWB TITLE STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (RESIDUES 13-345); COMPND 5 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE COMPND 6 13, STPK13; COMPND 7 EC: 2.7.11.21; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK1, PLK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS CATALYTIC DOMAIN, PLK1, POLO-LIKE KINASE1, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.-H.DING,M.KOTHE,D.KOHLS,S.LOW REVDAT 6 21-FEB-24 2OWB 1 REMARK REVDAT 5 20-OCT-21 2OWB 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 2OWB 1 VERSN REVDAT 3 24-FEB-09 2OWB 1 VERSN REVDAT 2 21-AUG-07 2OWB 1 JRNL REVDAT 1 24-APR-07 2OWB 0 JRNL AUTH M.KOTHE,D.KOHLS,S.LOW,R.COLI,A.C.CHENG,S.L.JACQUES, JRNL AUTH 2 T.L.JOHNSON,C.LEWIS,C.LOH,J.NONOMIYA,A.L.SHEILS, JRNL AUTH 3 K.A.VERDRIES,T.A.WYNN,C.KUHN,Y.H.DING JRNL TITL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE JRNL TITL 2 1. JRNL REF BIOCHEMISTRY V. 46 5960 2007 JRNL REFN ISSN 0006-2960 JRNL PMID 17461553 JRNL DOI 10.1021/BI602474J REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 22445 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1205 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1436 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2379 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 256 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.29000 REMARK 3 B22 (A**2) : 2.29000 REMARK 3 B33 (A**2) : -3.43000 REMARK 3 B12 (A**2) : 1.14000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.209 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.181 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.140 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.600 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2484 ; 0.006 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2326 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3351 ; 0.926 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5412 ; 0.745 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 293 ; 5.177 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 363 ; 0.055 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2700 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 524 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 471 ; 0.168 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2672 ; 0.209 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1477 ; 0.078 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 188 ; 0.114 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.111 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 48 ; 0.196 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.170 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1470 ; 0.311 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2393 ; 0.591 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1014 ; 0.738 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 958 ; 1.336 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2OWB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041664. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23735 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05700 REMARK 200 FOR THE DATA SET : 24.9500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN BUFFER: 50 MM HEPES, PH 7.5, 5 REMARK 280 MM TCEP. PROTEIN WAS INCUBATED ON ICE WITH 5 MM LIGAND (1:20 REMARK 280 DILUTION OF 100 MM STOCK IN H2O FOR AMPPNP OR DMSO FOR PHA- REMARK 280 680626) FOR 0.5-1 H, FOLLOWED BY A BRIEF CENTRIFUGATION STEP AND REMARK 280 DROP SETTING AT RT (0.5 MICROLITER PROTEIN + 0.5 MICROLITER REMARK 280 RESERVOIR SOLUTION CONSISTING OF 500 MM MAGNESIUM ACETATE, 10 % REMARK 280 PEG 4000 AND 0.3 MM ZINC ACETATE FOR AMPPNP, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 102.39333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 51.19667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 51.19667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 102.39333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -99.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 102.39333 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 11 REMARK 465 PRO A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ALA A 15 REMARK 465 ASP A 16 REMARK 465 PRO A 17 REMARK 465 GLY A 18 REMARK 465 LYS A 19 REMARK 465 ALA A 20 REMARK 465 GLY A 21 REMARK 465 VAL A 22 REMARK 465 PRO A 23 REMARK 465 GLY A 24 REMARK 465 VAL A 25 REMARK 465 ALA A 26 REMARK 465 ALA A 27 REMARK 465 PRO A 28 REMARK 465 GLY A 29 REMARK 465 ALA A 30 REMARK 465 PRO A 31 REMARK 465 ALA A 32 REMARK 465 ALA A 33 REMARK 465 ALA A 34 REMARK 465 PRO A 35 REMARK 465 PRO A 36 REMARK 465 SER A 331 REMARK 465 LEU A 332 REMARK 465 ASP A 333 REMARK 465 PRO A 334 REMARK 465 SER A 335 REMARK 465 ASN A 336 REMARK 465 ARG A 337 REMARK 465 LYS A 338 REMARK 465 PRO A 339 REMARK 465 LEU A 340 REMARK 465 THR A 341 REMARK 465 VAL A 342 REMARK 465 LEU A 343 REMARK 465 ASN A 344 REMARK 465 LYS A 345 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 38 88.84 65.42 REMARK 500 ASP A 122 -168.81 -116.74 REMARK 500 ARG A 135 32.71 -99.79 REMARK 500 ARG A 136 -129.88 63.23 REMARK 500 LYS A 146 -127.78 50.10 REMARK 500 ARG A 175 -0.12 72.96 REMARK 500 ASP A 176 42.13 -145.21 REMARK 500 ASP A 194 82.45 55.05 REMARK 500 SER A 229 -143.94 -151.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 93 NE2 REMARK 620 2 CYS A 212 SG 115.9 REMARK 620 3 CYS A 255 SG 97.3 124.0 REMARK 620 4 ACT A 502 O 109.9 95.5 114.7 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 626 A 500 DBREF 2OWB A 13 345 UNP P53350 PLK1_HUMAN 13 345 SEQADV 2OWB GLY A 11 UNP P53350 CLONING ARTIFACT SEQADV 2OWB PRO A 12 UNP P53350 CLONING ARTIFACT SEQADV 2OWB VAL A 210 UNP P53350 THR 210 ENGINEERED MUTATION SEQRES 1 A 335 GLY PRO ALA PRO ALA ASP PRO GLY LYS ALA GLY VAL PRO SEQRES 2 A 335 GLY VAL ALA ALA PRO GLY ALA PRO ALA ALA ALA PRO PRO SEQRES 3 A 335 ALA LYS GLU ILE PRO GLU VAL LEU VAL ASP PRO ARG SER SEQRES 4 A 335 ARG ARG ARG TYR VAL ARG GLY ARG PHE LEU GLY LYS GLY SEQRES 5 A 335 GLY PHE ALA LYS CYS PHE GLU ILE SER ASP ALA ASP THR SEQRES 6 A 335 LYS GLU VAL PHE ALA GLY LYS ILE VAL PRO LYS SER LEU SEQRES 7 A 335 LEU LEU LYS PRO HIS GLN ARG GLU LYS MET SER MET GLU SEQRES 8 A 335 ILE SER ILE HIS ARG SER LEU ALA HIS GLN HIS VAL VAL SEQRES 9 A 335 GLY PHE HIS GLY PHE PHE GLU ASP ASN ASP PHE VAL PHE SEQRES 10 A 335 VAL VAL LEU GLU LEU CYS ARG ARG ARG SER LEU LEU GLU SEQRES 11 A 335 LEU HIS LYS ARG ARG LYS ALA LEU THR GLU PRO GLU ALA SEQRES 12 A 335 ARG TYR TYR LEU ARG GLN ILE VAL LEU GLY CYS GLN TYR SEQRES 13 A 335 LEU HIS ARG ASN ARG VAL ILE HIS ARG ASP LEU LYS LEU SEQRES 14 A 335 GLY ASN LEU PHE LEU ASN GLU ASP LEU GLU VAL LYS ILE SEQRES 15 A 335 GLY ASP PHE GLY LEU ALA THR LYS VAL GLU TYR ASP GLY SEQRES 16 A 335 GLU ARG LYS LYS VAL LEU CYS GLY THR PRO ASN TYR ILE SEQRES 17 A 335 ALA PRO GLU VAL LEU SER LYS LYS GLY HIS SER PHE GLU SEQRES 18 A 335 VAL ASP VAL TRP SER ILE GLY CYS ILE MET TYR THR LEU SEQRES 19 A 335 LEU VAL GLY LYS PRO PRO PHE GLU THR SER CYS LEU LYS SEQRES 20 A 335 GLU THR TYR LEU ARG ILE LYS LYS ASN GLU TYR SER ILE SEQRES 21 A 335 PRO LYS HIS ILE ASN PRO VAL ALA ALA SER LEU ILE GLN SEQRES 22 A 335 LYS MET LEU GLN THR ASP PRO THR ALA ARG PRO THR ILE SEQRES 23 A 335 ASN GLU LEU LEU ASN ASP GLU PHE PHE THR SER GLY TYR SEQRES 24 A 335 ILE PRO ALA ARG LEU PRO ILE THR CYS LEU THR ILE PRO SEQRES 25 A 335 PRO ARG PHE SER ILE ALA PRO SER SER LEU ASP PRO SER SEQRES 26 A 335 ASN ARG LYS PRO LEU THR VAL LEU ASN LYS HET ZN A 501 1 HET ACT A 502 4 HET ACT A 503 4 HET 626 A 500 32 HETNAM ZN ZINC ION HETNAM ACT ACETATE ION HETNAM 626 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5- HETNAM 2 626 DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE FORMUL 2 ZN ZN 2+ FORMUL 3 ACT 2(C2 H3 O2 1-) FORMUL 5 626 C23 H24 N6 O2 S FORMUL 6 HOH *256(H2 O) HELIX 1 1 SER A 87 LEU A 89 5 3 HELIX 2 2 LYS A 91 SER A 107 1 17 HELIX 3 3 SER A 137 LYS A 146 1 10 HELIX 4 4 THR A 149 ASN A 170 1 22 HELIX 5 5 LYS A 178 GLY A 180 5 3 HELIX 6 6 ALA A 219 SER A 224 1 6 HELIX 7 7 PHE A 230 GLY A 247 1 18 HELIX 8 8 CYS A 255 ASN A 266 1 12 HELIX 9 9 ASN A 275 LEU A 286 1 12 HELIX 10 10 ASP A 289 ARG A 293 5 5 HELIX 11 11 THR A 295 ASN A 301 5 7 HELIX 12 12 ASP A 302 SER A 307 1 6 HELIX 13 13 PRO A 315 THR A 320 5 6 SHEET 1 A 6 VAL A 43 ASP A 46 0 SHEET 2 A 6 ARG A 51 GLY A 62 -1 O ARG A 51 N ASP A 46 SHEET 3 A 6 ALA A 65 ASP A 72 -1 O CYS A 67 N LEU A 59 SHEET 4 A 6 VAL A 78 PRO A 85 -1 O GLY A 81 N PHE A 68 SHEET 5 A 6 PHE A 125 LEU A 130 -1 O LEU A 130 N ALA A 80 SHEET 6 A 6 PHE A 116 GLU A 121 -1 N PHE A 120 O PHE A 127 SHEET 1 B 2 VAL A 172 ILE A 173 0 SHEET 2 B 2 THR A 199 LYS A 200 -1 O THR A 199 N ILE A 173 SHEET 1 C 2 LEU A 182 LEU A 184 0 SHEET 2 C 2 VAL A 190 ILE A 192 -1 O LYS A 191 N PHE A 183 LINK NE2 HIS A 93 ZN ZN A 501 1555 1555 2.22 LINK SG CYS A 212 ZN ZN A 501 1555 1555 2.22 LINK SG CYS A 255 ZN ZN A 501 6555 1555 2.23 LINK ZN ZN A 501 O ACT A 502 1555 1555 2.24 SITE 1 AC1 4 HIS A 93 CYS A 212 CYS A 255 ACT A 502 SITE 1 AC2 6 HIS A 93 GLN A 94 LYS A 97 CYS A 212 SITE 2 AC2 6 LEU A 256 ZN A 501 SITE 1 AC3 7 LYS A 178 LEU A 179 GLY A 180 ASN A 216 SITE 2 AC3 7 TYR A 217 HOH A 624 HOH A 674 SITE 1 AC4 17 ARG A 57 PHE A 58 LEU A 59 GLY A 62 SITE 2 AC4 17 ALA A 65 LYS A 66 CYS A 67 ALA A 80 SITE 3 AC4 17 LYS A 82 GLU A 131 CYS A 133 ARG A 134 SITE 4 AC4 17 ARG A 136 PHE A 183 HOH A 514 HOH A 538 SITE 5 AC4 17 HOH A 545 CRYST1 66.931 66.931 153.590 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014941 0.008626 0.000000 0.00000 SCALE2 0.000000 0.017252 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006511 0.00000